白血病分子诊疗技术.ppt

白血病分子诊疗技术;WH0血液肿瘤分类方案（1999年）;WH0血液肿瘤分类方案（2008年）;白血病分子诊疗意义;WHO血液肿瘤新分类试验技术平台;基因检测 ——融合基因 基因突变;“二次打击”学说;CML Indications for Diagnostic Tests Milestones and Monitoring in Patients with CML Treated with Imatinib (2008 ASH Education Program Book p420) Test Indication Physical Exam Diagnosis/Staging Every three month until resolution of splenomegaly Suspected progression or resistance Complete Blood Count Diagnosis/Staging Every 1-2 weeks until blood count have stabilized, then at 6 we